DNA Sequencing Markets (Next-Generation Systems, Capillary Systems, Consumables, Services)

Sep 7, 2012
180 Pages - Pub ID: KLI4871738
Attention: There is an updated edition available for this report.
Abstract Table of Contents Search Inside Report Related Reports

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
    • New Systems, Services Create Uncertainty
    • A Period of Rapid Adoption, But Lower Prices
    • Further Longer-Term Challenges
    • Rapid Growth Overall, But Intense Competition
    • Customers’ Research Models Evolving
    • Established Next-Generation Systems Seeing Slowdown
  • Background
    • Scope and Methodology
    • Applications and Definitions
    • Types of Samples
    • DNA Sequencing Strategies
CHAPTER TWO: SEQUENCER MARKET TRENDS
  • Industry and Technology Trends
    • Market Fragmenting Into Multiple Product Types and Applications
    • Continual Improvements Expand Sequencer Market
    • Acquisitions and Collaborations for New Technologies
    • Patent Infringement, Other Legal Disputes
    • Slow Path to Potentially Large Clinical Markets
    • Spread of Targeted Enrichment, Sequence-Capture Products and Services
    • Synergies Appearing Between Life Science Companies’ Products
    • Consumer Genomics, Genetic Testing, Pharmacogenetics Still Entering Mainstream
  • NHGRI Funding, Budget, Periodic Strategic Planning
    • NHGRI Shifts Funds from Centralized Sequencing Centers
    • NHGRI White Paper #4: The Future of Genome Sequencing
  • Genome Projects and Consortia
    • The Cancer Genome Atlas (TCGA) Project
    • National Plant Genome Initiative
    • NSF/USDA Microbial Genome Sequencing Program
CHAPTER THREE: DNA SEQUENCING SYSTEMS AND TECHNOLOGIES
  • 454 Life Sciences (Roche)
    • Genome Sequencer FLX, FLX+, Junior
    • Illumina
      • HiSeq, HiScan SQ, MiSeq, Genome Analyzer IIx
      • Intelligent Biosystems (Qiagen)/Azco Biotech
      • LI-COR Biosciences 4300
      • Life Technologies/Applied Biosystems
      • ABI Prism 310 Genetic Analyzer
      • ABI Prism 3100-Avant Genetic Analyzer
        • Applied Biosystems 3100 Genetic Analyzer
        • Applied Biosystems 3130 Genetic Analyzer
        • Applied Biosystems 3130xl Genetic Analyzer
        • Applied Biosystems 3500 Genetic Analyzer
        • Applied Biosystems 3730 DNA Analyzer
        • Applied Biosystems 3730xl DNA Analyzer
        • ABI SOLiD 4, 5500, 5500xl, 5500xl W Genetic Analyzers
        • Ion Torrent Personal Genome Machine (PGM)
      • Pacific Biosciences
        • PacBio RS
      • Technologies Under Development
        • Introduction
        • Human Microbiome Project Technology Development Awards
CHAPTER FOUR: SEQUENCING MARKET ANALYSIS
  • Revenues Forecast
  • Historical Revenues
  • Overall Market Forecast
  • Sequencing For a Clinical Purpose
    • Roche
    • ABI
    • Illumina
    • Affymetrix
    • B.C. Cancer Agency
    • Emory Genetics Lab
    • Bacterial and Viral Applications for NGS
    • eGenomics
    • BGI
    • Pacific Biosciences
    • Clinical Sequencing vs. Research Sequencing Markets
CHAPTER FIVE: COMPETITIVE ANALYSIS
  • Introduction
    • Benchtop and Third-Generation Sequencers Bring Instability
    • Second-, Third-Generation Battle Still Undefined, Unresolved
    • Increased Flexibility with Purchasing
    • ABI Capillary Electrophoresis Holds Onto Large Segment
  • DNA Sequencer Market Shares
    • Smaller Companies Experiencing Struggles
  • Features and Strengths of Second-Generation Sequencers
    • 454 Life Sciences GS FLX–Strengths/Advantages
    • 454 Life Sciences GS FLX–Weaknesses/Disadvantages
    • 454 Life Sciences GS Junior–Strengths/Advantages
    • 454 Life Sciences GS Junior–Weaknesses/Disadvantages
    • Applied Biosystems SOLiD–Strength/Advantages
    • Applied Biosystems SOLiD–Weaknesses/Disadvantages
    • Illumina HiSeq/HiScan SQ–Strength/Advantages
    • Illumina HiSeq/HiScan SQ–Weaknesses/Disadvantages
    • Illumina MiSeq - Strength/Advantages
    • Illumina MiSeq-Weaknesses/Disadvantages
    • Life Technologies PGM-Weaknesses/Disadvantages
    • Pacific Biosciences PacBio RS-Strength/Advantages
    • Pacific Biosciences PacBio RS-Weaknesses/Disadvantages
CHAPTER SIX: INTELLECTUAL PROPERTY AND LITIGATION
  • Developments
    • Helicos’ Patent Infringement Suit Against PacBio, Life Technologies, and Illumina
    • Intelligent Bio-Systems and Columbia University Sue Illumina for Infringement
    • Illumina’s Two Lawsuits Against Complete Genomics for Infringement
    • Illumina Sues Life Technologies Over Ion Torrent Systems
    • Class Action Shareholder Lawsuit Filed Against Pacific Biosciences
    • Affymetrix Dismisses Suit Against Pacific Biosciences and Former Employees
    • Life Technologies Defeats VisiGen Stakeholders After Arbitration
    • Catalyst Assets Sues Life Technologies for Infringement
    • Patent Interference Between Life Technologies and Pacific Biosciences
    • Life Technologies and Illumina Dispute Over Amplification on Solid Surfaces
    • LadaTech Sues Illumina Over DNA Amplification Patent
    • Illumina Files ‘841 Patent Infringement Suit Against Affymetrix
    • Affymetrix and Illumina Settle Case Over ‘243, ‘432, ‘531, ‘365, and ‘716
    • Applied Biosystems and Illumina Claims and Counter-claims Over Sequencing-by-Ligation Both Unsuccessful
    • Fluidigm and Applied Biosystems Agree to End Case
    • Beckman Coulter and Applied Biosystems Settle Outstanding Legal Disputes
    • Cepheid and Idaho Technology Settle Dispute Over PCR Patents
    • Enzo Biochem Disputes CalTech Sequencing Patents
    • Huang v. CalTech
    • Applied Biosystems and Amersham plc (GE Healthcare) Settle Sequencing Patent Litigation
    • Early ABI (Life Technologies) Patents
CHAPTER SEVEN: DEALS
  • List of Deals in the Sequencing Industry
CHAPTER EIGHT: CORPORATE PROFILES
  • 454 Life Sciences (Roche)
  • Complete Genomics
  • Illumina
  • Life Technologies
  • Pacific Biosciences
CHAPTER NINE: CHALLENGES AND STRATEGIC RECOMMENDATIONS
  • Market Challenges
    • Fragmentation of Market Complicates Competition
    • and several others....
  • Strategic Recommendations
    • Intense Competition Requires Constant Innovation
    • and several others...

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: DNA Sequencer Revenues, 2001-2011
CHAPTER TWO: SEQUENCER MARKET TRENDS
  • Table 2-1: NHGRI Budget by Year Including ARRA Supplement, 2006-2012
  • Figure 2-1: NHGRI Budget including ARRA (2006-2012)
  • Table 2-2: Est. NHGRI Budget by Mechanism, 2012 ($M)
  • Figure 2-2: NHGRI Budget
  • Table 2-3: NHGRI Budget by Activity, 2010-2012 ($thou)
  • Figure 2-3: NHGRI Budget by Activity, 2012
  • Table 2-4: NHGRI Funding, Large-Scale Sequencing Centers ‘07&’12
  • Figure 2-4: NHGRI Funding, Large-Scale Sequencing Centers ‘07&’12
  • Table 2-5: NHGRI Funding, Centers for Mendelian Genomics, 2012
  • Figure 2-5: NHGRI Funding, Centers for Mendelian Genomics, 2012
  • Table 2-6: NHGRI Clinical Sequencing Exploratory Research Awards, 2012
  • Table 2-7: Fuge Funding Recipients
  • Table 2-8: Plant Genome Comparative Sequencing Program (PGCSP) Awards, FY 2011
  • Table 2-9: NSF / USDA Microbial Genome Sequencing Program Awards, 2008-2011
  • Table 2-10 Other Initiatives and Consortia Using DNA Sequencing, 2012
CHAPTER THREE: DNA SEQUENCING SYSTEMS AND TECHNOLOGIES
  • Table 3-1: DNA Sequencer Products/ Technologies, 2012
  • Table 3-2: NIH Human Microbiome Project Technology Dev’t Awards, 2010
  • Table 3-3: NHGRI $1,000 Genome Grant Awards, 2009
  • Table 3-4: NHGRI $1,000 Genome Grant Awards, 2010
  • Table 3-5: NHGRI $1,000 Genome Grant Awards, 2011
  • Table 3-6: NHGRI Advanced Sequencing Technology Awardees, 2009
  • Table 3-7: NHGRI Medical Sequencing Discovery Awards, 2009
  • Table 3-8: NHGRI Understanding Genome Function Awards, 2009
  • Table 3-9: NHGRI Population Genomics Awards, 2009
  • Table 3-10: NHGRI Advanced Sequencing Technology Awardees, 2009
  • Table 3-11: Other Initiatives and Consortia Supporting Technology Development, 2012
CHAPTER FOUR: SEQUENCING MARKET ANALYSIS
  • Figure 4-1: Cost of Sequencing a Genome
  • Table 4-1: Market Forecast by Segment (Systems, Consumables, Services) , 2011-2016
  • Table 4-2: Sequencing Market Revenues Growth Rates by Segment, 2011-2016 (Systems, Consumables, Services)
  • Table 4-3: Sequencer Equipment Market, 2001-2011 ($M)
  • Table 4-4: Growth Rates, Sequencer Equipment Market, 2001-2011 ($M)
  • Figure 4-3: Sequencer Equipment Market, 2001-2011 ($M)
  • Figure 4-4: ABI Sequencing Revenues, Q3 2001 – Q3 2008
  • Figure 4-5: ABI Sequencing Revenues, Focus on Q4 2004 – Q3 2008
  • Figure 4-6: DNA Sequencer Market Forecast, 2011-2016:
  • Figure 4-7: Breakout of DNA Sequencing Market by Application(Clinical vs. Research) 2011
  • Figure 4-8: Breakout of DNA Sequencing Market by Application(Clinical vs. Research) 2016
CHAPTER FIVE: COMPETITIVE ANALYSIS
  • Table 5-1: DNA Sequencer Market Shares
  • Figure 5-1: DNA Sequencer Market Shares
  • Figure 5-2: Pacific Biosciences Quarterly Revenues, 2011-2012 ($M)
  • Figure 5-3: Complete Genomics Quarterly Revenues, 2010-2012 ($M)
  • Table 5-2 Comparison of Sequencers’ Performance, mid-2012
CHAPTER SIX: INTELLECTUAL PROPERTY AND LITIGATION
  • Table 6-1: Patents
CHAPTER SEVEN: DEALS
  • Table 7-1: Deals in the Sequencer Market
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
White Paper: DNA Sequencing Moves into Clinical Applications
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Bioinformatics in IVD Testing
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Food Safety Diagnostics, The World Market
Mass Spectrometry in Clinical Applications
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Home About Us My Account Personal Library Contact Us
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
9/30/2014 - 40
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST